Valuation: Olympus Corporation

Market Cap 1,886B 11.62B 10.19B 9.44B 8.68B 16.43B 1,112B 16.75B 112B 44.12B 546B 43.63B 42.67B P/E 2027 *
19.5x
P/E 2028 * 16.2x
Enterprise Value 1,956B 12.05B 10.57B 9.79B 9.01B 17.03B 1,153B 17.37B 117B 45.75B 566B 45.24B 44.25B EV / Sales 2027 *
1.84x
EV / Sales 2028 * 1.75x
Free-Float
94.53%
Yield 2027 *
1.74%
Yield 2028 * 1.82%
1 day+1.25%
1 week+0.42%
Current month+4.50%
1 month+4.26%
3 months+13.20%
6 months-14.86%
Current year-10.53%
1 week 1,729.5
Extreme 1729.5
1,818
1 month 1,610
Extreme 1610
1,818
Current year 1,302.5
Extreme 1302.5
2,137
1 year 1,302.5
Extreme 1302.5
2,168
3 years 1,302.5
Extreme 1302.5
2,867
5 years 1,302.5
Extreme 1302.5
3,198
10 years 758.75
Extreme 758.75
3,198
Manager TitleAgeSince
Chief Executive Officer 63 2025-05-31
Director of Finance/CFO 59 2026-03-31
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Chairman 69 2023-03-31
Director/Board Member 41 2019-05-31
Director/Board Member 63 2019-05-31
Change 5-day change 1-year change 3-year change Capi.($)
+1.25%+0.42%+4.04%-19.44% 11.53B
+0.21%+2.07%+24.21%+0.31% 196B
+0.27%-5.56%-20.85%+17.81% 144B
+0.41%+3.19%+1.03%-16.34% 141B
-0.46%+0.24%-57.15%-15.32% 66.54B
-0.15%-3.57%+17.25%-1.40% 53.09B
+2.80%+1.95%-22.68%-30.55% 44.12B
-0.85%+1.65%+10.56%+11.24% 37.93B
-1.37%-1.78%+22.35%+38.22% 36.96B
+0.87%+0.66%-12.34%-19.82% 29.43B
Average +0.27%-0.76%-3.36%-3.53% 76.04B
Weighted average by Cap. +0.22%-0.83%-1.44%-1.43%

Financials

2027 *2028 *
Net sales 1,065B 6.56B 5.76B 5.33B 4.9B 9.28B 628B 9.46B 63.54B 24.92B 308B 24.64B 24.1B 1,107B 6.82B 5.98B 5.54B 5.1B 9.64B 652B 9.83B 66B 25.89B 320B 25.6B 25.04B
Net income 98.47B 607M 532M 493M 453M 858M 58.06B 874M 5.87B 2.3B 28.51B 2.28B 2.23B 118B 724M 635M 588M 541M 1.02B 69.32B 1.04B 7.01B 2.75B 34.04B 2.72B 2.66B
Net Debt 69.9B 431M 378M 350M 322M 609M 41.22B 621M 4.17B 1.64B 20.24B 1.62B 1.58B 51.9B 320M 280M 260M 239M 452M 30.6B 461M 3.1B 1.21B 15.03B 1.2B 1.17B
Logo Olympus Corporation
Olympus Corp is a Japan-based company mainly engaged in the manufacture and sale of endoscopes, therapeutic equipment, scientific and other products. The Company operates through three business segments. The Endoscope segment provides gastrointestinal endoscopes, surgical endoscopes, and medical services. The Therapeutic Equipment segment provides gastrointestinal treatment instruments, urology products, respiratory products, energy devices, otolaryngology products and gynecology products. The Others segment provides biomaterials and orthopedic instruments. The Company is also engaged in the business activities, including holding companies and financial investments related to each business.
Employees
28,138
Date Price Change Volume
26-07-13 ¥1,775.50 +1.25% 3,629,900
26-07-10 ¥1,753.50 +0.72% 3,945,500
26-07-09 ¥1,741.00 -1.64% 3,166,800
26-07-08 ¥1,770.00 -1.12% 4,558,100
26-07-07 ¥1,790.00 +1.47% 5,393,700
Trader
Investor
Global
Quality
ESG MSCI
BB
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
14
Last Close Price
1,775.50JPY
Average target price
1,913.08JPY
Spread / Average Target
+7.75%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 7733 Stock